Sho Aoki

STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target

T. Koyama, O. Miura, A. Arai, 2018, Oncotarget.

Expression, mutation, and methylation of cereblon‐pathway genes at pre‐ and post‐lenalidomide treatment in multiple myeloma

S. Iida, M. Tohkin, K. Kubo, 2020, Cancer science.

Aggregation-prone A53T mutant of α-synuclein exaggerates methamphetamine neurotoxicity in SH-SY5Y cells: Protective role of cellular cholesterol

K. Uemura, T. Aki, T. Funakoshi, 2022, Toxicology reports.

Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunits

S. Iida, H. Komatsu, S. Ichikawa, 2018, Oncotarget.

Potent antitumor effect of combination therapy with sub-optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma.

S. Iida, H. Komatsu, T. Ishida, 2018, Oncology letters.

Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma

S. Iida, H. Komatsu, S. Kusumoto, 2019, International Journal of Hematology.